CLU Insider Trading Activity and SEC Form 4 Filings
CLU insider trading summary
No open-market insider purchases or sales of Cellu Tissue Holdings, Inc. (CLU) have been reported on SEC Form 4 in the past 12 months.
Latest CLU insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 27, 2010 | David L Ferguson | Director | Sell | $118.9M (9,911,317 @ $12.00) |
| Dec 27, 2010 | Weston Presidio V LP | 10% Owner | Sell | $118.9M (9,911,317 @ $12.00) |
| Dec 27, 2010 | R. Sean Honey | Director | Sell | $118.9M (9,911,317 @ $12.00) |
| Dec 27, 2010 | Weston Presidio Management V, LLC | 10% Owner | Sell | $118.9M (9,911,317 @ $12.00) |
| Jan 27, 2010 | Steven D Ziessler | Pres. Tissue & Mach-Gl, COO | Sell | $1.6M (123,841 @ $13.00) |
| Jan 27, 2010 | David L Ferguson | Director | Sell | $62.0M (4,765,735 @ $13.00) |
| Jan 27, 2010 | Weston Presidio V LP | 10% Owner | Sell | $62.0M (4,765,735 @ $13.00) |
| Jan 27, 2010 | David J Morris | Sr. V.P. Finance, CFO | Sell | $578K (44,427 @ $13.00) |
| Jan 27, 2010 | Russell Clyde Taylor | President, CEO | Sell | $8.3M (637,253 @ $13.00) |
| Jan 27, 2010 | Weston Presidio Management V, LLC | 10% Owner | Sell | $62.0M (4,765,735 @ $13.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.